Research and analysis

ACRE advice: prostate cancer vaccine trial

The Advisory Committee on Releases to the Environment's advice on an application for a trial of a genetically modified cancer vaccine.

Document

Detail

This document is the Advisory Committee on Releases to the Environment’s (ACRE) advice to government in considering a request from BN ImmunoTherapeutics for a clinical trial of a genetically modified (GM) vaccine.

The trial would be part of the company’s research into prostate cancer and based in Northern Ireland.

The committee decided that the trial would have no risk to human health or the environment, and recommended that the application should be approved.